Full Text View
Tabular View
No Study Results Posted
Related Studies
Subcutaneous Injection of Human Brain Natriuretic Peptide (BNP), Natrecor (Nesiritide), to Improve Kidney and Hormonal Function of People With Abnormal Function of the Heart
This study has been completed.
Study NCT00387621   Information provided by Mayo Clinic
First Received: October 12, 2006   Last Updated: January 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Congestive Heart Failure
Additional conditions recognized in this trial
Heart Failure
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Interventions listed in this trial
Human BNP Natrecor (nesiritide)
Additional drug interventions recognized in this trial
Natriuretic Peptide, Brain
More general drug interventions related to this trial
Cardiovascular Agents
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Mayo Clinic
National Institutes of Health (NIH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services